drugset

drugset / Trial / NCT01101945

Long-term Extension Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

NCT01101945 ↗

Phase 2 Terminated 339 enrolled Phenomix

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to demonstrate that dutogliptin/PHX1149T is safe and tolerable.

Timeline

Start: 2007-07
Primary completion: 2010-01
Completion: 2010-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dutogliptin	Small molecule	400 mg	—

Indications